By directing and funding paradigm-shifting research initiatives; educating patients, healthcare professionals, and the public; and advocating for survivors and their families, AIM at Melanoma’s goal is to end this disease in our lifetime while improving the lives of those it affects.
Founded in 2004, AIM at Melanoma is a global foundation dedicated to finding more effective treatments and, ultimately, the cure for melanoma.
AIM at Melanoma is dedicated to:
Innovation in Melanoma Research
We believe that the cure for melanoma will be found more quickly by bringing together leading global researchers and funding their collaborative research. Our paradigm-shifting global research initiatives, including the International Melanoma Tissue Bank Consortium, are poised to reshape the future of melanoma.
Legislation, Policy & Advocacy
We are the respected voice of melanoma across the nation. When drugs are approved, legislation is drafted, and research is assessed, AIM is at the table, speaking loudly and clearly on behalf of patients and their families. We are trusted advisors for government agencies, medical boards, and pharmaceutical companies on critical topics that affect melanoma patients.
Information & Support
Both in the U.S. and on a global level we provide comprehensive, easy-to-access melanoma resources for patients and health care professionals. AIM’s patient, family, and caregiver support offerings—such as our Ask an Expert service, which allows patients to contact a melanoma physician assistant with their questions, and our Peer Connect program, which matches newly diagnosed patients with melanoma veterans—serve as models for other cancer foundations.
The Story Behind AIM at Melanoma Foundation
It wasn’t right that Charlie Guild lost her battle with melanoma at 26. But in terms of the positive impact her story would have on the melanoma community, she had the right mother.